Gil Rabinovici, MD

Gil Rabinovici, MD, is the Edward and Pearl Fein Distinguished Professor in the University of California San Francisco (UCSF) Departments of Neurology, Radiology & Biomedical Imaging. He received his BS degree from Stanford University and MD from Northwestern University Medical School. He completed neurology residency (and chief residency) at UCSF and a behavioral neurology fellowship at the UCSF Memory and Aging Center.  

Dr. Rabinovici’s work investigates how structural, functional and molecular brain imaging techniques can be used to improve diagnostic accuracy in dementia and to study the biology of neurodegenerative diseases, with the goal of accelerating drug development. He is Director of the NIH-funded UCSF Alzheimer’s Disease Research Center, study chair of the Imaging Dementia-Evidence for Amyloid Scanning (IDEAS) and New IDEAS studies, as well as co-PI on the emerging Alzheimer’s Network for Treatment and Diagnostics (ALZ-NET), co-PI and PET Core lead of the Longitudinal Evaluation of Alzheimer’s Disease Study (LEADS) and PI on several additional national and local clinical, imaging and translational studies focused on AD and related disorders. He is also an Associate Editor for JAMA (and previously JAMA Neurology). Dr. Rabinovici’s research is supported by NIH, Alzheimer’s Association, American College of Radiology, Rainwater Charitable Foundation, private foundations and industry partners.  

Previous awards include the 2025 Potamkin Prize for Research in Pick’s, Alzheimer’s, and Related Diseases from the American Academy of Neurology and the American Brain Foundation, 2022 Kuhl-Lassen Award from the Society for Nuclear Medicine and Molecular Imaging,  2015 Christopher Clark Award in Amyloid Imaging, the 2012 American Academy of Neurology Research Award in Geriatric Neurology and the 2010 deLeon Prize from the Alzheimer’s Association.